Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

NCT05684978 is registered in ClinicalTrials.gov with Wayne State University as lead sponsor.

NCT NCT05684978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05684978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
Lead sponsor
Wayne State University
Phase
Phase 4
Overall status
Terminated
Start date
October 10, 2025
Completion date
October 10, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory status epilepticus